Impact of COVID-19 pandemic on cancer care: A cross-sectional study of Egyptian patients' perspectives and concerns.
COVID-19 and healthcare accessibility
Cancer care adjustments
Egyptian cancer patients and survivors
Healthcare provision
Modification of cancer treatment
Online survey
Patients’ concerns, beliefs, and knowledge
Patients’ perspectives
Remote consultations
Journal
Journal of cancer policy
ISSN: 2213-5383
Titre abrégé: J Cancer Policy
Pays: England
ID NLM: 101639933
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
12
07
2022
revised:
06
08
2022
accepted:
19
08
2022
pubmed:
26
8
2022
medline:
21
12
2022
entrez:
25
8
2022
Statut:
ppublish
Résumé
Worldwide, COVID-19 greatly reduced healthcare accessibility and utilization by non-COVID patients including cancer. This study aimed to quantify and characterize cancer care adjustments experienced by cancer patients/survivors; and to explore their concerns, beliefs, and knowledge regarding COVID-19. A cross-sectional study was conducted using a questionnaire distributed through social media patients' groups (June-December 2020). Questionnaire included basic information, care adjustments (in "care provision" and in "treatment plan"), and patients' concerns, beliefs, and knowledge. Data description and analysis were done. Out of 300 participants, there were 68.0% on-treatment and 32.0% in follow-up stage. Care adjustments were reported by 29.7%; mostly in care provision (27.3%) rather than treatment plan (4.9%). Adjustments were less likely to occur when healthcare facility was in governorate other than that of residence (OR:0.53, 95%CI:0.30-0.96, P = 0.037) and more likely with long-standing diagnosis (≥12 months) compared with recent (<3 months) (adjusted-OR:4.13, 95%CI:1.19-14.34, P = 0.026). Lower proportion of on-treatment patients used remote consultation than patients in follow-up [4.4% versus 17.7%, P < 0.001]. Patients were concerned about fulfilling their care visits more than the probable COVID-19 infection (72.3%). It was uncommon to feel that the risk of COVID-19 infection is higher in care places than in the community (27.3%) or to feel safe with remote consultations (34.3%). However, patients increased their infection control practice (64.0%) and the majority were aware of their increased susceptibility to complications (86.0%). Somewhat, they were also concerned about the care quality (57.3%). Many had adequate access to COVID-19 information (69.0%) and their main sources were the Ministry of Health webpage and ordinary media (radio/TV). Cancer patients were primarily concerned about fulfilling their planned care and COVID-19 infection was less appreciated. Launching of a policy for enhancement of telemedicine experience through more patients' engagement-as essential stakeholders-may be required. To heighten pandemic resilience for cancer care in Egypt, more investment in establishing specialized end-to-end cancer care facilities that ensure continuity of care may be justified.
Sections du résumé
BACKGROUND
Worldwide, COVID-19 greatly reduced healthcare accessibility and utilization by non-COVID patients including cancer. This study aimed to quantify and characterize cancer care adjustments experienced by cancer patients/survivors; and to explore their concerns, beliefs, and knowledge regarding COVID-19.
METHODS
A cross-sectional study was conducted using a questionnaire distributed through social media patients' groups (June-December 2020). Questionnaire included basic information, care adjustments (in "care provision" and in "treatment plan"), and patients' concerns, beliefs, and knowledge. Data description and analysis were done.
RESULTS
Out of 300 participants, there were 68.0% on-treatment and 32.0% in follow-up stage. Care adjustments were reported by 29.7%; mostly in care provision (27.3%) rather than treatment plan (4.9%). Adjustments were less likely to occur when healthcare facility was in governorate other than that of residence (OR:0.53, 95%CI:0.30-0.96, P = 0.037) and more likely with long-standing diagnosis (≥12 months) compared with recent (<3 months) (adjusted-OR:4.13, 95%CI:1.19-14.34, P = 0.026). Lower proportion of on-treatment patients used remote consultation than patients in follow-up [4.4% versus 17.7%, P < 0.001]. Patients were concerned about fulfilling their care visits more than the probable COVID-19 infection (72.3%). It was uncommon to feel that the risk of COVID-19 infection is higher in care places than in the community (27.3%) or to feel safe with remote consultations (34.3%). However, patients increased their infection control practice (64.0%) and the majority were aware of their increased susceptibility to complications (86.0%). Somewhat, they were also concerned about the care quality (57.3%). Many had adequate access to COVID-19 information (69.0%) and their main sources were the Ministry of Health webpage and ordinary media (radio/TV).
CONCLUSION
Cancer patients were primarily concerned about fulfilling their planned care and COVID-19 infection was less appreciated.
POLICY SUMMARY
Launching of a policy for enhancement of telemedicine experience through more patients' engagement-as essential stakeholders-may be required. To heighten pandemic resilience for cancer care in Egypt, more investment in establishing specialized end-to-end cancer care facilities that ensure continuity of care may be justified.
Identifiants
pubmed: 36007875
pii: S2213-5383(22)00038-8
doi: 10.1016/j.jcpo.2022.100359
pmc: PMC9395284
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100359Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declarations of interest None.
Références
J Natl Compr Canc Netw. 2020 Mar 20;:1-4
pubmed: 32197238
Eur J Cancer. 2020 Nov;139:43-50
pubmed: 32971510
Lancet Oncol. 2021 Jul;22(7):970-976
pubmed: 34051879
Ann Oncol. 2020 Oct;31(10):1320-1335
pubmed: 32745693
Ann Intern Med. 2020 Jun 2;172(11):756-758
pubmed: 32219410
Eur J Cancer. 2020 Sep;136:132-139
pubmed: 32683273
JCO Clin Cancer Inform. 2020 Nov;4:1059-1071
pubmed: 33253013
PLoS One. 2021 Sep 17;16(9):e0257420
pubmed: 34534231
Ecancermedicalscience. 2021 Jul 07;15:1263
pubmed: 34567248